Skip to content

Use Of Homoeopathy in Hyperuricemia

THE ROLE OF HOMOEOPATHIC MEDICINES USING BOGER BOENNINGHAUSEN S CHARACTERISTICS & REPERTORY IN HYPERURICEMIA AN OPEN LABEL PROSPECTIVE, CLINICAL STUDY - NIL

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/01/079809
Enrollment
40
Registered
2025-01-30
Start date
Unknown
Completion date
Unknown
Last updated
2025-03-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: - Health Condition 2: E790- Hyperuricemia without signs of inflammatory arthritis and tophaceous disease

Interventions

Intervention1: Homoeopathic medicines after repertorization done by using BBCR.: Patients qualifying to inclusion criteria will be included in the study .proper casetaking of all enrolled patientswiil

Sponsors

National Institute of Homeopathy
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients with hyperuricemia either with or without active gout symptoms.

Exclusion criteria

Exclusion criteria: Patient with high risk to lead kidney disease like nephropathy nephrolithiasis. Patients in need of surgical interventions & advanced cases with deformities will be excluded. Patients with known but controlled systemic diseases. Patient already undergoing homeopathic treatment of other chronic disease will be excluded. Pregnant and lactating mothers. Patients suffering from uncontrolled systemic illness any psychiatric illness or life - threatening infections. Patient both male & female with more than 12 mg/dl Serum uric acid.

Design outcomes

Primary

MeasureTime frame
Each enrolled case will be followed up monthly, with scores recorded at the time of patient entry (baseline), and the difference in serum uric acid levels will be assessed in 6 monthsTimepoint: Each enrolled case will be followed up monthly, with scores recorded at the time of patient entry (baseline), and the difference in serum uric acid levels will be assessed in 6 months.

Secondary

MeasureTime frame
NOT APPLICABLETimepoint: NOT APPLICABLE

Countries

India

Contacts

Public ContactDr Avijit shee burman

National Institute of Homeopathy

asheeburman@gmail.com9433392108

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026